HomepageDOCM • SWX
add
DocMorris
Vorige slotkoers
CHF 4,97
Dag-range
CHF 4,87 - CHF 4,99
Jaar-range
CHF 3,92 - CHF 12,26
Beurswaarde
254,37 mln. CHF
Gem. volume
238,82K
Koers/winst
-
Dividendrendement
-
Primaire beurs
SWX
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 291,49 mln. | 11,95% |
Bedrijfskosten | 86,90 mln. | 3,46% |
Netto inkomsten | -36,42 mln. | -22,79% |
Netto winstmarge | -12,49 | -9,66% |
Winst per aandeel | — | — |
EBITDA | -19,38 mln. | 24,72% |
Effectief belastingtarief | -18,92% | — |
Balans
Totale activa
Totale passiva
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 159,48 mln. | 67,22% |
Totale activa | 825,40 mln. | 6,07% |
Totale passiva | 416,35 mln. | -4,95% |
Totaal aandelenvermogen | 409,06 mln. | — |
Uitstaande aandelen | 48,11 mln. | — |
Koers-boekwaardeverhouding | 0,58 | — |
Rendement op activa | -6,79% | — |
Rendement op kapitaal | -8,03% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CHF) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -36,42 mln. | -22,79% |
Operationele kasstroom | -16,48 mln. | -121,78% |
Kasstroom uit beleggingen | 18,10 mln. | -64,02% |
Kasstroom uit financiering | -16,56 mln. | 65,00% |
Nettomutatie in liquide middelen | -15,20 mln. | -212,10% |
Vrije kasstroom | -10,44 mln. | 42,77% |
Over
DocMorris AG, formerly Zur Rose Group, is an online pharmacy operating in Germany, the Netherlands, Spain, France and Switzerland. Its services are offered under various brands, DocMorris being the most well-known one. It has developed into a comprehensive digital health service provider including e-commerce pharmacy, marketplace and professional health products and services. The DocMorris shares are listed on the SIX Swiss Exchange. As of 2023 it had more than 10 million active customers. Wikipedia
CEO
Opgericht
mrt 1993
Hoofdvestiging
Website
Werknemers
1.337
